Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring
Hon Shing Ong(Duke-NUS Medical School), Jodhbir S. Mehta(Singapore National Eye Center), Andri K. Riau(Singapore Eye Research Institute), Tze-Wei Goh(Singapore Eye Research Institute), Evelina Han(Singapore Eye Research Institute), Nur Zahirah Binte M. Yusoff(Singapore Eye Research Institute), Gary Hin‐Fai Yam(Singapore Eye Research Institute), Ruenn Chai Lai(Tessa Therapeutic (Singapore)), Sai Kiang Lim(Io Therapeutics (United States))
Cited by 45
Related Papers
Defining mesenchymal stromal cell (MSC)‐derived small extracellular vesicles for therapeutic applications
|Journal of Extracellular Vesicles|2019|652
Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome
|International Journal of Proteomics|2012|493
TFOS DEWS II iatrogenic report
|The Ocular Surface|2017|444
Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstruction
|Biomaterials|2009|261
Sustained Delivery System for Stem Cell-Derived Exosomes
|Frontiers in Pharmacology|2019|232